Factors associated with late-stage presentation of cervical cancer in Ghana

Ghana Med J. 2022 Jun;56(2):86-94. doi: 10.4314/gmj.v56i2.5.

Abstract

Objective: To explore factors associated with late clinical presentation among Ghanaian women with cervical cancer.

Design: This is a cross-sectional survey using a paper questionnaire.

Setting: Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana.

Participants: Participants were women presenting for cervical cancer care at KATH. Inclusion criteria were histologically diagnosed cervical cancer and age ≥18 years. The exclusion criteria was age <18. All women presenting from August 2018-August 2019 were recruited.

Main outcome measures: The primary outcome was the proportion of participants presenting with late-stage cervical cancer, defined as stage II or higher.

Results: Of 351 total participants, 33.6% were unemployed, 35.3% had no formal education, and 96.6% had an average monthly income of less than five hundred Ghana cedis ($86 USD). Time from symptoms to seeing a doctor ranged from fewer than two weeks (16.0%) to more than twelve months (8.6%). Participants' most common barrier in seeking healthcare was financial constraints (50.0%). Most participants presented at late-stage cervical cancer (95.2%, n=334), with only 4.8% (n=17) presenting at stage I. Of participants presenting with late-stage cervical cancer, the vast majority had never had a Papanicolaou (Pap) smear (99.1%) nor a recent gynecologic exam (99.3%). After adjusting for age, parity, and distance to a healthcare facility, a late-stage presentation was associated with lower income and living in a rural area.

Conclusions: In Ghana, 95% of women with cervical cancer seek care at a late clinical stage, defined as stage II or greater, when the cancer is inoperable.

Funding: None declared.

Keywords: Ghana; gynecologic neoplasm; uterine cervical cancer; uterine cervical neoplasms.

MeSH terms

  • Adolescent
  • Cervix Uteri / pathology
  • Cross-Sectional Studies
  • Female
  • Ghana / epidemiology
  • Humans
  • Male
  • Papanicolaou Test
  • Uterine Cervical Neoplasms* / diagnosis
  • Uterine Cervical Neoplasms* / epidemiology